Search

Search Constraints

You searched for: Author/Creator Takeda, Haruhiko

Search Results

1. Branched‐chain amino acid to tyrosine ratio is an essential pre‐treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinoma. (4th October 2020)

2. Clinical characteristics of collagenous colitis with linear ulcerations. Issue 1 (7th April 2013)

3. Clinical characteristics of collagenous colitis with linear ulcerations. Issue 1 (7th April 2013)

4. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan. (10th June 2014)

5. Effect of treatment with branched‐chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma. Issue 3 (29th April 2013)

6. Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection. Issue 1 (December 2018)

8. Mac‐2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinoma. (17th April 2021)

9. Multiregional whole‐genome sequencing of hepatocellular carcinoma with nodule‐in‐nodule appearance reveals stepwise cancer evolution. Issue 4 (29th September 2020)

10. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus. (22nd February 2021)